搜索
Galecto Ord Shs
DMRA添加自选
26.430USD
-0.170-0.64%
收盘 04/20, 16:00（美东）报价延迟15分钟
42.22M总市值
亏损市盈率 TTM
关于 公司
Galecto Ord Shs简介
公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -
Galecto Ord Shs公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Interim Principal Executive Officer, Chief Operating Officer
Interim Principal Executive Officer, Chief Operating Officer
190.38K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
+94.14%
Mr. Garrett Winslow
Mr. Garrett Winslow
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
1.85K
+22.92%
Ms. Lori Firmani
Ms. Lori Firmani
Interim Chief Financial Officer
Interim Chief Financial Officer
931.00
+25.67%
Dr. Jayson D.A. Dallas, M.D.
Dr. Jayson D.A. Dallas, M.D.
Independent Director
Independent Director
--
--
Dr. Carl M. Goldfischer, M.D.
Dr. Carl M. Goldfischer, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Amit D. Munshi
Mr. Amit D. Munshi
Independent Director
Independent Director
--
-100.00%
Mr. Matthew (Matt) Kronmiller
Mr. Matthew (Matt) Kronmiller
Executive Vice President of Strategy, Chief Business Officer
Executive Vice President of Strategy, Chief Business Officer
--
--
Mr. Peter Harwin
Mr. Peter Harwin
Independent Director
Independent Director
--
--
Dr. Chris W. Cain, Ph.D.
Dr. Chris W. Cain, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Interim Principal Executive Officer, Chief Operating Officer
Interim Principal Executive Officer, Chief Operating Officer
190.38K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
+94.14%
Mr. Garrett Winslow
Mr. Garrett Winslow
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
1.85K
+22.92%
Ms. Lori Firmani
Ms. Lori Firmani
Interim Chief Financial Officer
Interim Chief Financial Officer
931.00
+25.67%
Dr. Jayson D.A. Dallas, M.D.
Dr. Jayson D.A. Dallas, M.D.
Independent Director
Independent Director
--
--
Dr. Carl M. Goldfischer, M.D.
Dr. Carl M. Goldfischer, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 4月13日 周一
更新时间: 4月13日 周一
持股股东
股东类型
持股股东
持股股东
占比
VR Adviser, LLC
5.98%
Ikarian Capital LLC
0.56%
Hewes (Lemuel Becker)
0.44%
Fidelity Management & Research Company LLC
0.40%
Sattarzadeh (Sherwin)
0.32%
其他
92.32%
持股股东
持股股东
占比
VR Adviser, LLC
5.98%
Ikarian Capital LLC
0.56%
Hewes (Lemuel Becker)
0.44%
Fidelity Management & Research Company LLC
0.40%
Sattarzadeh (Sherwin)
0.32%
其他
92.32%
股东类型
持股股东
占比
Venture Capital
6.02%
Individual Investor
1.06%
Hedge Fund
0.94%
Investment Advisor
0.68%
Corporation
0.40%
Investment Advisor/Hedge Fund
0.34%
Research Firm
0.13%
其他
90.42%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
52
4.80M
7.95%
+3.88M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
VR Adviser, LLC
3.60M
5.98%
+3.60M
--
Feb 09, 2026
Ikarian Capital LLC
335.71K
0.56%
+50.00K
+17.50%
Feb 28, 2026
Hewes (Lemuel Becker)
264.63K
0.44%
+264.63K
--
Jan 05, 2026
Fidelity Management & Research Company LLC
238.88K
0.4%
--
--
Dec 31, 2025
Sattarzadeh (Sherwin)
190.38K
0.32%
+190.38K
--
Jan 05, 2026
Bruno (Julianne)
137.03K
0.23%
+129.00K
+1606.08%
Feb 09, 2026
Jain Global LLC
120.57K
0.2%
+120.57K
--
Dec 31, 2025
Remedium Capital Partners, LLC
120.47K
0.2%
+120.47K
--
Dec 31, 2025
Paramora Holding LLC
120.47K
0.2%
+120.47K
--
Nov 10, 2025
Paragon Therapeutics Inc
120.47K
0.2%
+120.47K
--
Nov 10, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
